Cargando…

The Impact of Isolation on Elderly Patients with Mild to Moderate COVID-19

OBJECTIVES: Patients with mild to moderate COVID-19 who require hospitalization are prone to physical inactivity. This study examined the impact of mild to moderate COVID-19 on the activities of daily living (ADLs) of patients who received rehabilitation therapy. METHODS: Between February 1, 2020, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugiyama, Mizuki, Kasai, Fumihito, Kawate, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JARM 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240098/ https://www.ncbi.nlm.nih.gov/pubmed/35854684 http://dx.doi.org/10.2490/prm.20220032

Ejemplares similares

Immediate effect of different ankle-foot orthosis functions with the same dorsiflexed setting of initial ankle joint angle on walking ability in individuals with chronic stroke: a randomized crossover trial
por: Nojiri, Eri, et al.
Publicado: (2022)

Limitation of developmental test to measure functional independence of children: Relationship between the Japanese version of WeeFIM II® and KSPD
por: Sugiyama, Mizuki, et al.
Publicado: (2022)

Association of Spinal Alignment and Abdominal Circumference with Sarcopenia Status and Fall Risk in Patients with Osteoporosis: A Retrospective Study
por: Nagai, Takashi, et al.
Publicado: (2023)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Functional dependency and COVID-19 in elderly patients with mild to moderate disease. Experience of tertiary geriatric hospital
por: Emily, Lubart, et al.
Publicado: (2022)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
por: Dougan, Michael, et al.
Publicado: (2021)

Kidney outcome after mild to moderate COVID-19
por: Schmidt-Lauber, Christian, et al.
Publicado: (2023)

Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
por: Lechien, Jerome R., et al.
Publicado: (2022)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Newly diagnosed diabetes in patients with mild to moderate COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021)

Psychological effect of mild to moderate COVID-19 on hospitalised patients
por: Aziz, Sadaf, et al.
Publicado: (2022)

Mild-to-Moderate Croup Presentations in Patients With COVID-19 Infection
por: Mathew, Danica, et al.
Publicado: (2022)

Mildly Elevated Serum Bilirubin Levels Are Negatively Associated with Carotid Atherosclerosis among Elderly Persons
por: Kawamoto, Ryuichi, et al.
Publicado: (2014)

Impact of mild-moderate mitral regurgitation on outcomes of isolated aortic valve replacement
por: Chia, Rong Hui (Misté), et al.
Publicado: (2015)

Mild-to-moderate COVID-19 impact on the cardiorespiratory fitness in young and middle-aged populations
por: Back, G.D., et al.
Publicado: (2022)

Prediction of the Rehabilitation Duration and Risk Management for Mild-Moderate COVID-19
por: Zheng, Qiong-Na, et al.
Publicado: (2020)

Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
por: Kravchenko, Dmitrij, et al.
Publicado: (2021)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Neurological manifestations in mild and moderate cases of COVID-19
por: Abdel Azim, Ghada Saed, et al.
Publicado: (2021)

Depression Following COVID-19 Lockdown in Severely, Moderately, and Mildly Impacted Areas in China
por: Han, Xuerui, et al.
Publicado: (2021)

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19
por: Brock, Patricia, et al.
Publicado: (2021)

Effectiveness and Safety of Regdanvimab in Patients With Mild-To-Moderate COVID-19: A Retrospective Cohort Study
por: Park, Susin, et al.
Publicado: (2022)

Euphorbia neriifolia Leaf Juice on Mild and Moderate COVID-19 Patients: Implications in OMICRON Era
por: Pramanik, Md Enayet Ali, et al.
Publicado: (2022)

Vascular Risk as a Predictor of Cognitive Decline in a Cohort of Elderly Patients with Mild to Moderate Dementia
por: Curiati, Pedro K., et al.
Publicado: (2014)

The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer’s Disease
por: Ohnishi, Takashi, et al.
Publicado: (2014)

New Therapeutic Options in Mild Moderate COVID-19 Outpatients
por: Ucciferri, Claudio, et al.
Publicado: (2022)

Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
por: Ramirez, Francisco E., et al.
Publicado: (2021)

Mild Hyperglycaemia in Hospitalised Children with Moderate COVID-19 Infection
por: Vojtková, Jarmila, et al.
Publicado: (2023)

Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
por: Bryushkova, Ekaterina A., et al.
Publicado: (2022)

Smell and Taste Symptoms Among Patients With Mild and Moderately Severe COVID-19 Infection in Uganda
por: Byaruhanga, Richard, et al.
Publicado: (2022)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience
por: Tascini, Carlo, et al.
Publicado: (2020)

Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective
por: Hossain, Mehrab E, et al.
Publicado: (2021)

The role of antibiotic prophylaxis in mild to moderate isolated hydronephrosis detected in antenatal screening
por: Rianthavorn, Pornpimol, et al.
Publicado: (2020)

Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
por: Joshi, Shashank, et al.
Publicado: (2022)

Roles of Early Mobilization Program in Preventing Muscle Weakness and Decreasing Psychiatric Disorders in Patients with Coronavirus Disease 2019 Pneumonia: A Retrospective Observational Cohort Study
por: Kotani, Toru, et al.
Publicado: (2021)

Thrombomodulin in patients with mild to moderate bleeding tendency
por: Mehic, Dino, et al.
Publicado: (2021)

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
por: Fowler, Joseph, et al.
Publicado: (2023)

Neurological manifestations of patients with mild-to-moderate COVID-19 attending a public hospital in Lima, Peru
por: Carcamo Garcia, Marco H., et al.
Publicado: (2021)

The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection
por: dos Santos, Patty K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lvdd1oqvdqvolqlnkh938oraff